NFKB1 and cancer: The constitutive and aberrant activation of c-MET mediated by NF-κB contribution provokes several downstream signaling pathways (MAPK, PI3K/AKT, STAT3) which subsequently promote cancer proliferation, survival, progression, angiogenesis, invasion and metastasis.